Slingshot members are tracking this event:

AstraZeneca (AZN) announces receipt of FDA CRL regarding its high potassium drug ZS-9

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 17, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Zs-9, High Potassium, Crl